Immunosuppressive therapy in renal transplantation. 1990

T N Fedric

Despite advances in organ procurement and surgical techniques, immunosuppressant therapy continues to present a challenge to graft survival in renal transplantation. It also challenges nurses to give the best care possible. In order to do this, nurses must understand how the immune system functions. They must be able to apply this knowledge to the actions of the immunosuppressant agents their parents are receiving. Immunosuppressant therapy is two-fold. First, it is used to prevent rejection and maintain the function of the graft. Its second use is to reverse acute rejection. The major drugs used in maintenance therapy are the corticosteroids, azathioprine, and cyclosporine. The drugs used in acute rejection are antilymphocyte sera, high-dose corticosteroids, and OKT3. These drugs place the patient at risk for a myriad of serious side effects. By being aware of these side effects, the nurse is able to detect their early signs and symptoms and intervene appropriately.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

T N Fedric
October 1971, The Surgical clinics of North America,
T N Fedric
August 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
T N Fedric
January 1984, Springer seminars in immunopathology,
T N Fedric
September 2002, Transplantation proceedings,
T N Fedric
November 1988, Comprehensive therapy,
T N Fedric
June 2002, Expert opinion on biological therapy,
Copied contents to your clipboard!